Rallybio Corporation (RLYB) - Quarterly Income Statement

Home
RLYB
Financials

0.535 (USD) • At close August 1, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0.212	0.038	0.299	0.299	0	0.228	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0	0.034	0.035	0.036	0.037	0.038	0.039	0	0.042	0.044	0.042	0.035	0.026	0.025	0.023	0	0	0	0
Gross Profit Numbers are in millions	0.212	0.008	0.299	0.265	-0.035	0.192	-0.037	-0.038	-0.039	0	-0.042	-0.044	-0.042	-0.035	-0.026	-0.025	-0.023	0	0	0	0
Gross Profit Ratio Numbers are in millions	1	0.211	1	0.886	0	0.842	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	5.725	7.355	8.24	12.912	12.901	15.888	13.288	13.13	11.202	10.793	12.11	10.138	7.648	6.094	4.96	6.818	9.037	7.495	5.13	3.092	1.913
General & Administrative Expenses Numbers are in millions	4.157	4.261	4.125	4.388	6.851	5.188	6.075	6.953	7.172	6.298	6.75	7.477	6.67	6.219	5.021	3.712	3.787	2.592	1.58	1.57	1.931
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	4.157	4.261	4.125	4.388	6.851	5.188	6.075	6.953	7.172	6.298	6.75	7.477	6.67	6.219	5.021	3.712	3.787	2.592	1.58	1.57	1.931
Other Expenses Numbers are in millions	0	0	0	0.143	0.167	0.035	0.092	0.062	0.073	0	0.098	0.1	0.113	0.109	0	0	0.024	0.068	0.052	0	0
Operating Expenses Numbers are in millions	9.882	11.616	12.365	17.3	19.752	21.076	19.363	20.083	18.374	17.091	18.86	17.615	14.318	12.313	9.981	10.53	12.824	10.087	6.71	4.662	3.844
Operating Income Numbers are in millions	-9.67	-11.608	-12.066	-17.035	-19.787	-21.112	-19.363	-20.083	-18.374	-17.091	-18.86	-17.615	-14.318	-12.313	-9.981	-10.53	-12.824	-10.087	-6.71	-4.662	-3.844
Operating Income Ratio Numbers are in millions	-45.613	-305.474	-40.355	-56.973	0	-92.596	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0.231	0.564	0.6	0.799	0.758	1.483	0.989	1.453	1.056	1.102	0.49	0.37	0.21	0.121	0.117	-0.129	0.031	-0.43	0.081	0.104	0.095
Income Before Tax Numbers are in millions	-9.439	-11.044	-11.466	-15.749	-18.344	-19.629	-18.374	-18.413	-16.755	-15.989	-18.237	-17.245	-14.108	-12.192	-9.864	-10.659	-12.793	-10.004	-6.629	-4.558	-3.749
Income Before Tax Ratio Numbers are in millions	-44.524	-290.632	-38.348	-52.672	0	-86.092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	-0.43	0	0.487	0.685	0	-0.037	0.217	-1.095	0.214	-0.434	0.068	0	0.102	0.437	0	0	0.001	0	0	-0.016
Net Income Numbers are in millions	-9.439	-11.044	-11.466	-16.236	-19.029	-20.242	-18.374	-18.63	-15.66	-16.203	-17.803	-17.583	-14.401	-12.415	-10.196	-11.127	-13.275	-10.518	-7.155	-4.893	-3.881
Net Income Ratio Numbers are in millions	-44.524	-290.632	-38.348	-54.301	0	-88.781	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.21	-0.25	-0.26	-0.37	-0.47	-0.5	-0.45	-0.46	-0.39	-0.46	-0.58	-0.57	-0.47	-0.42	-0.37	-0.36	-0.6	-0.47	-0.32	-0.22	-0.17
EPS Diluted Numbers are in millions	-0.21	-0.25	-0.26	-0.37	-0.47	-0.5	-0.45	-0.46	-0.39	-0.46	-0.58	-0.57	-0.47	-0.42	-0.37	-0.36	-0.6	-0.47	-0.32	-0.22	-0.17
EBITDA Numbers are in millions	-9.642	-11.578	-12.034	-17.001	-19.752	-21.076	-19.326	-20.045	-18.335	-15.95	-18.195	-17.571	-14.066	-12.157	-9.838	-10.634	-12.76	-9.972	-6.601	-4.532	-3.724
EBITDA Ratio Numbers are in millions	-45.481	-304.684	-40.247	-56.86	0	-92.439	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Rallybio Corporation

NASDAQ:RLYB Add to watchlist

NASDAQ:RLYB